These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


96 related items for PubMed ID: 2848895

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. BSF1 induces membrane protein phosphorylation but not phosphoinositide metabolism, Ca2+ mobilization, protein kinase C translocation, or membrane depolarization in resting murine B lymphocytes.
    Justement L, Chen Z, Harris L, Ransom J, Sandoval V, Smith C, Rennick D, Roehm N, Cambier J.
    J Immunol; 1986 Dec 01; 137(11):3664-70. PubMed ID: 3023486
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Relationship between immunoglobulin production and immortalization by Epstein Barr virus.
    Tosato G, Blaese RM, Yarchoan R.
    J Immunol; 1985 Aug 01; 135(2):959-64. PubMed ID: 2989369
    [Abstract] [Full Text] [Related]

  • 27. Regulation of the growth of Epstein-Barr virus-infected B cells. I. Growth regression by E rosetting cells from VCA-positive donors is a combined effect of autologous mixed leukocyte reaction and activation of T8+ memory cells.
    Konttinen YT, Bluestein HG, Zvaifler NJ.
    J Immunol; 1985 Apr 01; 134(4):2287-93. PubMed ID: 2857749
    [Abstract] [Full Text] [Related]

  • 28. B cell superstimulatory influenza virus (H2-subtype) induces B cell proliferation by a PKC-activating, Ca(2+)-independent mechanism.
    Rott O, Charreire J, Semichon M, Bismuth G, Cash E.
    J Immunol; 1995 Mar 01; 154(5):2092-103. PubMed ID: 7868886
    [Abstract] [Full Text] [Related]

  • 29. Regulation of the BZLF1 promoter of Epstein-Barr virus by second messengers in anti-immunoglobulin-treated B cells.
    Daibata M, Speck SH, Mulder C, Sairenji T.
    Virology; 1994 Feb 01; 198(2):446-54. PubMed ID: 8291228
    [Abstract] [Full Text] [Related]

  • 30. T cell-mediated immunoregulation of Epstein Barr virus- (EBV) induced B lymphocyte activation in EBV-seropositive and EBV-seronegative individuals.
    Tosato G, Magrath IT, Blaese RM.
    J Immunol; 1982 Feb 01; 128(2):575-9. PubMed ID: 6274959
    [Abstract] [Full Text] [Related]

  • 31. Heterogeneity of EBV-transformable human B lymphocyte populations.
    Chan MA, Stein LD, Dosch HM, Sigal NH.
    J Immunol; 1986 Jan 01; 136(1):106-12. PubMed ID: 2999241
    [Abstract] [Full Text] [Related]

  • 32. Latent membrane protein 1 of Epstein-Barr virus plays an important role in the serum starvation resistance of Epstein-Barr virus-immortalized B lymphocytes.
    Park CH, Kim HR, Kim J, Jang SH, Lee KY, Chung GH, Jang YS.
    J Cell Biochem; 2004 Mar 01; 91(4):777-85. PubMed ID: 14991769
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Improvement of EBV transformation and cloning efficiency of human B cells using culture supernatants from lymphoblastoid cell lines.
    Mevissen ML, Kwekkeboom J, Goormachtig E, Lindhout E, de Groot C.
    Hum Antibodies Hybridomas; 1993 Apr 01; 4(2):66-73. PubMed ID: 8390865
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Combination of mutant EL-4 thymoma cells and EBV-infection in B lymphocyte activation a) EBV-infection of EL-4-activated lymphocytes. b) Use of EL-4 cells as feeders for lymphoblastoid cell lines.
    Barcellini W, Borghi MO, Nicoletti F, Bonara P, Fain C, Meroni PL.
    J Clin Lab Immunol; 1990 Sep 01; 33(1):21-8. PubMed ID: 1966941
    [Abstract] [Full Text] [Related]

  • 37. Properties of a specific interleukin 1 (IL 1) receptor on human Epstein Barr virus-transformed B lymphocytes: identity of the receptor for IL 1-alpha and IL 1-beta.
    Matsushima K, Akahoshi T, Yamada M, Furutani Y, Oppenheim JJ.
    J Immunol; 1986 Jun 15; 136(12):4496-502. PubMed ID: 3011895
    [Abstract] [Full Text] [Related]

  • 38. Shedding of anti-IgM from antibody-coated human lymphoma lines: differences between Epstein-Barr virus-negative lines and their virus-converted sublines.
    Yefenof E, Lundin L, Klein G.
    Eur J Immunol; 1978 Mar 15; 8(3):190-3. PubMed ID: 207534
    [Abstract] [Full Text] [Related]

  • 39. Protein kinase C regulates secretion of lymphotoxin (LT/TNF beta) and TNF alpha by human EBV-transformed B cells.
    Jochems GJ, Klein MR, Zeijlemaker WP, van Lier RA.
    Hum Antibodies Hybridomas; 1992 Oct 15; 3(4):162-7. PubMed ID: 1335785
    [Abstract] [Full Text] [Related]

  • 40. B cell triggering by bacterial lipopeptide involves both translocation and activation of the membrane-bound form of protein kinase C.
    Boscá L, Márquez C, Martínez C.
    J Immunol; 1991 Sep 01; 147(5):1463-9. PubMed ID: 1880413
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.